$United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)$

PremiumPress Releases

United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)

1M ago

MESO

PremiumPress Releases

Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer

2M ago

MESO

PremiumPress Releases

United States Food & Drug Administration (FDA) Supports Accelerated Approval Pathway for Rexlemestrocel-L in End-Stage Heart Failure Patients with a Left Ventricular Assist Device (LVAD)

2M ago

MESO

PremiumPress Releases

Mesoblast Reports Financial Results and Operational Update for Half-Year Ended December 31, 2023

2M ago

MESO

More MEOBF News >

MSB News on the Web

2024-04-08

4 pharma & biotech stocks on the move in March

Live Wire

Neutral

2024-04-05

Why is everyone talking about Mesoblast shares?

The Motley Fool

Neutral

2024-04-05

ASX Small Caps and IPO Weekly Wrap: A short week for a small win on the ASX

StockHead

Neutral

2024-04-05

Why the Mesoblast share price can rise another 60%

The Motley Fool

Neutral

2024-04-03

ASX Health Winners March: A rebound? Aussie biotech sector is on the radar of Asian investors

StockHead

Neutral

2024-04-03

Mesoblast share price dumps 10% as excitement simmers on FDA submission

The Motley Fool

Neutral

2024-04-02

Rise and Shine: Everything you need to know before the ASX opens

StockHead

Neutral

2024-04-02

Closing Bell: ASX too timid on Tuesday. Although Dart Mining has a decent Mesoblast

StockHead

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:MSB’s Media Buzz Sentiment?

Currently, no data Available

What is AU:MSB’s weekly average amount of articles?

Currently, no data Available

What is AU:MSB’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

CGEMCullinan Management

INSPInspire Medical Systems

EWEdwards Lifesciences

EVOEvotec AG

ELVElevance Health

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing